Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

RVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into ...

"Finding the exact binding site on the receptor offers the perfect template for developing ketamine-like drugs that could be administered orally and may lack the addictive potential of ketamine," says ...

PSA responses were seen both in patients with androgen receptor wild type (including androgen receptor amplification) and ligand binding domain mutations, the investigators pointed out. No grade 4 ...

Antibody makeup influences the severity of flu. Viruses are the fastest-evolving biological entity on earth. This fact ...

News Releases News Topics Media Advisories University Statements How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how   These ...

Weill Cornell Medicine researchers have determined the full-length structure of a blood pressure-regulating hormone receptor for the first time, uncovering how it functions, which may enable better ...

New research has revealed the diverse assembly and regulation of Type-A GABA receptors (GABAARs), which are crucial for ...

Weill Cornell Medicine researchers have determined the full-length structure of a blood pressure-regulating hormone receptor ...